INS and Insulin resistance: While Zfyve28 liver-specific overexpression in mice impairs insulin sensitivity and causes an increase in lipid content in the serum and liver, Zfyve28 liver-specific knockout significantly improves insulin sensitivity and relevant indicators associated with insulin resistance.